Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation
Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation
复制标题
DOI:
10.1006/bbrc.1996.1413
复制
发表时间:
1996-09-24
影响因子:
3.1
通讯作者:
Frangione, B
中科院分区:
文献类型:
--
作者:
Soto, C;Kindy, MS;Frangione, B
Amyloid beta-peptide (A beta) is a major fibrillar component of neuritic plaques in Alzheimer's disease (AD) brains and is related to the pathogenesis of the disease. We hypothesized that amyloid formation could be inhibited by peptides homologous to A beta (position 17-21) with a similar degree of hydrophobicity, but with a very low propensity to adopt a beta-sheet conformation by incorporating proline residues (anti-beta-sheet peptides or beta-sheet inhibitors). An 11-residue peptide with these characteristics binds to A beta, inhibits A beta fibril formation and partially disaggregates preformed fibrils in vitro. Shorter anti-beta-sheet peptides and analogs containing D-amino acids are also able to inhibit A beta fibrillogenesis. The latter are more resistant to proteolytic degradation and may serve as a starting point to design more efficient peptides derivatives to inhibit amyloidogenesis in vivo. (C) 1996 Academic Press, Inc.